Net Cash Provided by (Used in) Operating Activities |
-128K |
USD |
-56.2% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
3B |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.54M |
USD |
-5.11% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.82M |
USD |
+9.04% |
Dec 31, 2023 |
Q4 2023 |
Operating Lease, Liability |
274K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation |
7.33K |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.82M |
USD |
+9.04% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
8.95M |
USD |
+1.63% |
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
151K |
USD |
-49.4% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Share-based Payment Arrangement, Expense |
34.8K |
USD |
|
Mar 31, 2024 |
Q1 2024 |